Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20151017024572N17Phase 3Completed
Phase 3, open-label trial of medical ozonated water, triamcinolone, lidocaine and dextrose in shoulder tendinopathy (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Visual Analogue Scale and Shoulder Pain and Disability Index. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20151017024572N17.